Artificial lung

Inspira™ Technologies to Participate in Upcoming Events in May

Retrieved on: 
Tuesday, May 3, 2022
Company, FDA, OXY, Human, Food, Regulation of tobacco by the U.S. Food and Drug Administration, Artificial lung, Patient, ART, Medical device

Abut Inspira Technologies OXY B.H.N.

Key Points: 
  • Abut Inspira Technologies OXY B.H.N.
  • Ltd.
    Inspira Technologies is an innovative medical device company in the respiratory care industry.
  • Inspira Technologies is developing the ART device, a cost effective early extracorporeal respiratory support system with an intent to function as an "Artificial Lung" for deteriorating respiratory patients.
  • The Company's product has not yet been tested or used in humans and has not been approved by the U.S. Food and Drug Administration (FDA).

Draper Develops Artificial Lung Technology with $4.9M U.S. Army Grant, Earns ASAIO Award

Retrieved on: 
Thursday, July 29, 2021
Medicine, Medical specialties, Medical terminology, Medical equipment, Membrane technology, Clinical medicine, Intensive care medicine, Extracorporeal membrane oxygenation, Artificial lung, Extracorporeal, Oxygen saturation

CAMBRIDGE, Mass., July 29, 2021 /PRNewswire-PRWeb/ --Artificial lung assist devices have been called life-savers for people who suffer respiratory failure.

Key Points: 
  • CAMBRIDGE, Mass., July 29, 2021 /PRNewswire-PRWeb/ --Artificial lung assist devices have been called life-savers for people who suffer respiratory failure.
  • Draper has done just that, making advances in an artificial lung technology called extracorporeal membrane oxygenation, or ECMO.
  • The device can become clogged with blood clots, which diminishes the membrane's ability to transfer oxygen and CO2.
  • We provide unbiased assessments of technology or systems designed or recommended by other organizationscustom designed, as well as commercial-off-the-shelf.

Global Artificial Lung Devices Pipeline Insight and Competitive Landscape Report 2021: Comprehensive Insights About 20+ Companies and 23+ Pipeline Devices - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 22, 2021
Biotechnology, Health, Medical devices, Neonatology, Medical specialties, Health, Branches of biology, Syndromes, Artificial lung, Meconium aspiration syndrome, Lung, Meconium, Intensive care medicine

b'Artificial lung device is a prosthetic device works as an alternative to the biological lung.

Key Points: 
  • b'Artificial lung device is a prosthetic device works as an alternative to the biological lung.
  • It provides oxygenation of blood and removal of carbon dioxide from the blood.
  • Artificial lung devices are made of synthetic material that are connected to blood vessels through tubes and cannulas of silicone.\nThis segment of the artificial lung devices report encloses its detailed analysis of various pipeline devices which include product description, licensing and collaboration details and other developmental activities including latest news and press releases.
  • The report also provides list of major players involved in the pipeline product development.\nArtificial lung devices for decades have been used in newborns and children with lung failure, pneumonia, meconium aspiration syndrome and other conditions.

Oklahoma Firefighter and Father-of-Four Survives COVID-19 and Receives Lifesaving Lung Transplant at Dignity Health St. Joseph’s in Phoenix

Retrieved on: 
Friday, April 9, 2021
Medical specialties, Clinical medicine, Organ transplantation, Surgery, Artificial lung, Extracorporeal membrane oxygenation, Lung transplantation

PHOENIX, April 09, 2021 (GLOBE NEWSWIRE) -- A 44-year-old firefighter and father-of-four from Oklahoma recently received a lifesaving double lung transplant at Norton Thoracic Institute at Dignity Health St. Josephs Hospital and Medical Center in Phoenix after having survived COVID-19.

Key Points: 
  • PHOENIX, April 09, 2021 (GLOBE NEWSWIRE) -- A 44-year-old firefighter and father-of-four from Oklahoma recently received a lifesaving double lung transplant at Norton Thoracic Institute at Dignity Health St. Josephs Hospital and Medical Center in Phoenix after having survived COVID-19.
  • Essentially an artificial lung that oxygenates the blood, ECMO can be used to help support patients while their lungs recover.
  • When Blakes wife, Jenn, learned the doctors had called a lung transplant program in Arizona, she started researching online.
  • St. Josephs Norton Thoracic Institute was the third lung transplant program in the country to perform a lung transplant as a result of lung damage from COVID-19, and Blakes case is Nortons fourth post-COVID-19 lung transplant.

Extracorporeal Membrane Oxygenation Machine Market Size Is Projected to Reach $307.5 million by 2028 | Polaris Market Research

Retrieved on: 
Monday, March 15, 2021
Medicine, Medical terminology, Medical specialties, Medical equipment, Branches of biology, Membrane technology, Extracorporeal, Oxygen saturation, Artificial lung, EBOO

NEW YORK, March 15, 2021 /PRNewswire/ -- The extracorporeal membrane oxygenation machine market is estimated to cross USD 307.5 million by 2028according to a new study conducted by Polaris Market Research.

Key Points: 
  • NEW YORK, March 15, 2021 /PRNewswire/ -- The extracorporeal membrane oxygenation machine market is estimated to cross USD 307.5 million by 2028according to a new study conducted by Polaris Market Research.
  • This extracorporeal membrane oxygenation machine pumps and oxygenates an individual's blood, thereby reducing stress on damaged airways and heart.
  • Regional Developments and Key Insights:
    North America led the major growth for the extracorporeal membrane oxygenation machine market, followed by Europe.
  • Feel Free To Ask Our Industry Experts At : https://www.polarismarketresearch.com/industry-analysis/extracorporeal-m...
    Polaris Market research has segmented the extracorporeal membrane oxygenation machine market report on the basis of component, modality, patient type, application, and region:
    Extracorporeal Membrane Oxygenation Machine, Component Outlook (Revenue USD Million, 2016 2028)

Extracorporeal Membrane Oxygenation Machine Market Size Is Projected to Reach $307.5 million by 2028 | Polaris Market Research

Retrieved on: 
Monday, March 15, 2021
Medicine, Medical terminology, Medical specialties, Medical equipment, Branches of biology, Membrane technology, Extracorporeal, Oxygen saturation, Artificial lung, EBOO

NEW YORK, March 15, 2021 /PRNewswire/ -- The extracorporeal membrane oxygenation machine market is estimated to cross USD 307.5 million by 2028according to a new study conducted by Polaris Market Research.

Key Points: 
  • NEW YORK, March 15, 2021 /PRNewswire/ -- The extracorporeal membrane oxygenation machine market is estimated to cross USD 307.5 million by 2028according to a new study conducted by Polaris Market Research.
  • This extracorporeal membrane oxygenation machine pumps and oxygenates an individual's blood, thereby reducing stress on damaged airways and heart.
  • Regional Developments and Key Insights:
    North America led the major growth for the extracorporeal membrane oxygenation machine market, followed by Europe.
  • Feel Free To Ask Our Industry Experts At : https://www.polarismarketresearch.com/industry-analysis/extracorporeal-m...
    Polaris Market research has segmented the extracorporeal membrane oxygenation machine market report on the basis of component, modality, patient type, application, and region:
    Extracorporeal Membrane Oxygenation Machine, Component Outlook (Revenue USD Million, 2016 2028)

Global Artificial Lung Devices Pipeline Insight and Competitive Landscape Report 2020 - ResearchAndMarkets.com

Retrieved on: 
Friday, October 9, 2020
Health, Biotechnology, Artificial lung, Pipelines in Canada

The "Artificial Lung Devices Pipeline Insight and Competitive Landscape, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Artificial Lung Devices Pipeline Insight and Competitive Landscape, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • The Artificial Lung Devices - Pipeline Insight and Competitive Landscape, 2020, report provides comprehensive insights about 20+ companies and 23+ pipeline devices in artificial lung devices pipeline landscape.
  • Therefore, due to an increase in demand and more and more players investing in research and development activities there is an extensive pipeline of artificial lung devices.
  • This latest report has all the emerging artificial lung devices along with competitive landscape to help better understand the market scenario.

CVD Receives Applied Research & Development Award for Continued Development of ECMO Devices

Retrieved on: 
Monday, July 29, 2019
Chemicals, Plastics, Manufacturing, Technology, Nanotechnology, Pharmaceutical, Medical devices, Science, Biotechnology, Engineering, Research, Health, Medical equipment, Membrane technology, Intensive care medicine, Extracorporeal membrane oxygenation, Extracorporeal, Cardiopulmonary bypass, Natural sciences, Technology, Artificial lung

This collaboration will support continued development of CVDs advanced carbon-based fluid reactors which it first announced in press releases on November 14, 2018 and November 26, 2018 .

Key Points: 
  • This collaboration will support continued development of CVDs advanced carbon-based fluid reactors which it first announced in press releases on November 14, 2018 and November 26, 2018 .
  • CVD has developed a novel, patent-pending, fluid reactor system that is targeted to enable the design and manufacturing of an improved Extracorporeal Membrane Oxygenation (ECMO) device.
  • ECMO devices are utilized in heart-lung machines.
  • These fluid reactor devices are enabled by a family of novel Reactor Core Elements (RCE) made from free-standing, self-supporting, carbon-infiltrated c-VACNT material.